Blog - Page 1295 of 5712

MondayJul 19, 2021 10:38 am

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces Collaboration with University of Milan for ‘Precedent-Setting Experiment’

RYAH Group (CSE: RYAH) today announced its entry into a strategic partnership with the University of Milan, a leading education and research institution, to develop and formalize universal milliliter (“ml”) to milligram (“mg”) conversion standards in dry herb cannabis inhalation therapies for its RYAH Smart Dry Herb Inhalers. According to the update, the RYAH Smart Dry Herb Inhaler is an IoT-powered dry herb inhaler with an integrated volumetric airflow sensor that gives consumers the ability to track and control exactly how much they inhale. “Our collaboration with the University of Milan is expected to afford us an incredible opportunity to,…

MondayJul 19, 2021 10:22 am

QualityStocksNewsBreaks – Grapefruit USA Inc. (GPFT) Issues Statement on Senators Proposed Act to Legalize Cannabis

Grapefruit USA (OTCQB: GPFT), a premiere California-based cannabis and hemp company, has noted its position on the potential enactment of the Cannabis Administration and Opportunity Act. Senators Chuck Schumer (D-NY), Ron Wyden (D-OR) and Cory Booker (D-NJ) released a discussion draft of the act on July 14, 2021. As presented, the act would remove cannabis from the federal list of controlled substances, making cannabis use legal at the federal level. According to the company’s announcement, the act also enables states to implement their own adult-use recreational cannabis laws. Almost 20 states have already done that, including California, where Grapefruit is…

MondayJul 19, 2021 10:14 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Featured in Recent Stock Day Podcast Discussing CBD Nanoemulsion Milestones

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries, was featured in a recent episode of the Stock Day podcast. In the podcast, PBIO president and CEO Richard Schumacher the company’s recent nanoemulsion achievements with podcast host Everett Jolly. During the interview, Schumacher stated that the company recently transformed the potent antioxidant astaxanthin into a water-soluble compound, noting that astaxanthin, the most powerful nutritional antioxidant known to humans, is in short supply and is not easy to obtain. The substance is extracted from algae…

MondayJul 19, 2021 9:51 am

QualityStocksNewsBreaks – TAAT Global Alternatives Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) Provides Update on New Las Vegas Facility

TAAT(TM) Global Alternatives (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) has announced that work on its new facilities, which are located in Las Vegas and designed to ensure the company has ample capacity to meet forecast demand, is moving forward. Specifically, the company stated that all processing equipment, including mixers, shredders and conveyor belts, has been successfully moved into the new manufacturing facility with plans for additional machinery, including finishing equipment, to arrive in the coming weeks. Based on those dates, the company noted that the new manufacturing facility should be operational in August 2021. The announcement also noted that the new…

MondayJul 19, 2021 9:30 am

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Leverages Pandemic-Induced Trends, Changes in the Food & Beverage Industry Through Strategic Partnerships

PlantX Life recently launched as a seller on both Walmart Canada Marketplace and Hudson’s Bay Marketplace The launches appear to be leveraging the changes and trends brought about by the COVID-19 pandemic In addition, the agreements are part of PlantX’s growth strategy The company will offer thousands of its products on both platforms As the COVID-19 pandemic upended multiple aspects of life in Canada, it did not spare the retail industry. Here, it forced Canadians to rethink how, where and when they shop, with the paramount consideration in their decision-making process being their personal and family health and safety. Shopping…

MondayJul 19, 2021 9:30 am

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Acquisition Leads to Milestone Achievement, Positive Pre-Clinical Results

CYBN subsidiary Adelia Therapeutics has reached earn-out milestones. Adelia’s earn-out milestones contributed to positive preclinical results with multiple proprietary psychedelic molecules. Cybin’s development of these compounds differentiates it from companies focused on naturally occurring psychedelic compounds. Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has announced that earn-out milestones have been reached by its wholly controlled subsidiary Adelia Therapeutics Inc. These milestones, which were for the period commencing Jan. 1, 2021, add value to Cybin’s pipeline of novel psychedelic compounds (https://ibn.fm/Y1YPb). "These positive catalysts continue to provide the necessary data required to demonstrate that Cybin’s…

MondayJul 19, 2021 9:30 am

Golden Triangle Ventures Inc. (GTVH) Working to Develop, Commercialize First-of-Its-Kind Technology

GTVH, HyFrontier Technologies working together to offer a patent-pending hydrogen and oxygen delivery system for agriculture. Company has seen recent developments that could significantly benefit the entire agricultural industry. Duplicating enhanced-growth thunderstorms cause can reduce need for crop rotations, helping millions of people avoid starvation. A little more than a month after announcing its formal purchase agreement with HyFrontier Technologies (https://ibn.fm/RZkbo), Golden Triangle Ventures (OTC: GTVH) is making good on its commitment to pursue ventures in the technology sector to provide advanced technology for the modern era. GTVH and HyFrontier Technologies are working together to offer a patent-pending, first-of-its-kind hydrogen…

MondayJul 19, 2021 9:00 am

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Reports Successful Implementation and Testing of HealthTab(TM) in Shoppers Drug Mart(R) Locations

The program’s initial focus is to support those at risk or already diagnosed with diabetes or cardiovascular disease, offering better health management and quality of life In the United States, approximately 88 million adults live with prediabetes, and as many as 84% do not know they have it. It is estimated that by 2030, 13.6 million Canadians will be diabetic or prediabetic The global point-of-care diagnostics testing market was valued at $30.45 billion in 2021 and is anticipated to grow at a CAGR of 3.25%, resulting in a revenue forecast of $35.74 billion by 2028 Avricore Health Inc. (TSX.V: AVCR)…

MondayJul 19, 2021 9:00 am

DealMaker Webinar Features Industry Experts, Takes Closer Look at Reg A+ Distribution Channels

Industry experts share expertise, insight in next DealMaker webinar. Successful Reg A+ offerings tell their stories across multiple mediums. DealMaker is building a reputation for its ability to offer services that support companies across a wide array of needs. With its mission of delivering speed, innovation and efficiency to global capital markets in mind, DealMaker has scheduled its next webinar. Slated for July 20, 2021, at 12 noon ET, the event will feature Don Yocham, executive director of the National Institute of Cannabis Investors, and Ryan Bradford, director of digital marketing at Creative Direct Marketing Group as well as DealMaker’s…

FridayJul 16, 2021 1:48 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Stands Distinct in Precision Medicine

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is leveraging its unique, historical database of the drug responses of over 150,000 patient tumors to build data-driven predictive models of tumor drug response. These models will provide actionable insights critical to both new drug development and individualizing patient treatment. “While others must wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine,” a recent article reads. “Predictive Oncology presently has the clinical information, including tumor drug response data and…

Site Search

Company Search

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces Collaboration with University of Milan for ‘Precedent-Setting Experiment’

QualityStocksNewsBreaks – Grapefruit USA Inc. (GPFT) Issues Statement on Senators Proposed Act to Legalize Cannabis

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Featured in Recent Stock Day Podcast Discussing CBD Nanoemulsion Milestones

QualityStocksNewsBreaks – TAAT Global Alternatives Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) Provides Update on New Las Vegas Facility

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Leverages Pandemic-Induced Trends, Changes in the Food & Beverage Industry Through Strategic Partnerships

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Acquisition Leads to Milestone Achievement, Positive Pre-Clinical Results

Golden Triangle Ventures Inc. (GTVH) Working to Develop, Commercialize First-of-Its-Kind Technology

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Reports Successful Implementation and Testing of HealthTab(TM) in Shoppers Drug Mart(R) Locations

DealMaker Webinar Features Industry Experts, Takes Closer Look at Reg A+ Distribution Channels

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Stands Distinct in Precision Medicine

Market Basics

Newsletter Publishers

Public Companies